Company intelligence / Profile preview

Transdermal Delivery Solutions Corporation

Palm Beach Gardens, Florida, United States

Ownership: Private
Development stage: Other

Overview

The company has conducted clinical trials for hormone replacement technologies (Testagen® HypoSpray®) and has reached agreements with the FDA for safety studies of their transdermal delivery system. Their technology has shown promise in delivering drugs through the skin in an intact, bioavailable form.

Therapeutic areas: EndocrinologyNeurology
Modalities: Transdermal drug delivery systemsspray-on drug delivery
Industry: Biotech

Drug pipeline

1 asset

Testagen

Unknown

Partnerships

ALZYN, LLC

Beyond the preview

Go deeper on Transdermal Delivery Solutions Corporation.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transdermal Delivery Solutions Corporation.